Skip to content

ANAPTYSBIO, INC.

ANAB

CIK 0001370053

← back to feed
Revenue (TTM)
$151.91M
+157.0% YoY Q1 May 2026
Net Income (TTM)
−$115.73M
+90.9% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.94
+91.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-35.3%
Q1 May 2026
Net Margin
-76.2%
Q1 May 2026
Free Cash Flow (TTM)
−$98.69M
Q1 May 2026
Cash
$248.47M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
29.1M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings